Studying at the University of Verona
Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.
Study Plan
This information is intended exclusively for students already enrolled in this course.If you are a new student interested in enrolling, you can find information about the course of study on the course page:
Laurea magistrale in Molecular and Medical Biotechnology - Enrollment from 2025/2026The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.
1° Year
| Modules | Credits | TAF | SSD |
|---|
2 courses to be chosen among the followingOne course to be chosen among the following3 courses to be chosen among the followingOne course to be chosen among the following2° Year activated in the A.Y. 2017/2018
| Modules | Credits | TAF | SSD |
|---|
2 courses to be chosen among the following| Modules | Credits | TAF | SSD |
|---|
2 courses to be chosen among the followingOne course to be chosen among the following3 courses to be chosen among the followingOne course to be chosen among the following| Modules | Credits | TAF | SSD |
|---|
2 courses to be chosen among the followingLegend | Type of training activity (TTA)
TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.
Protein misfolding and human diseases (2016/2017)
Teaching code
4S003664
Teacher
Coordinator
Credits
6
Language
English
Scientific Disciplinary Sector (SSD)
BIO/10 - BIOCHEMISTRY
Period
II sem. dal Mar 1, 2017 al Jun 9, 2017.
Learning outcomes
This course aims to provide information on conformational disease, protein quality control system, chaperone,inherited disorders.
In particular, students will gain familiarity with PRINCIPLES OF PROTEIN MISFOLDING;PROTEIN MISFOLDING DISEASE;MEDICAL ASPECTS OF DISEASE: DIAGNOSIS AND CURRENT THERAPIES
Program
PRINCIPLES OF PROTEIN MISFOLDING
Why Proteins Misfold
Endoplasmic Reticulum Stress and Oxidative Stress:
Mechanisms and Link to Disease
Role of Molecular Chaperones in Protein Folding
Kinetic Models for Protein Misfolding and Association
Autophagy: An Alternative Degradation Mechanism
for Misfolded Proteins
Role of Posttranslational Modifications in Amyloid Formation
Caenorhabditis elegans as a Model System to Study the
Biology of Protein Aggregation and Toxicity
Animal Models to Study the Biology of Amyloid-b
Protein Misfolding in Alzheimer Disease
PROTEIN MISFOLDING DISEASE: GAIN-OF-FUNCTION AND LOSS-OF-FUNCTION DISEASES
Alzheimer Disease: Protein Misfolding, Model Systems,
and Experimental Therapeutics
Prion Disease Therapy
Misfolding and Aggregation in Huntington Disease
Systemic Amyloidoses
Copper–Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis
Alpha-1-Antitrypsin Deficiency
Folding Biology of Cystic Fibrosis: A Consortium-Based Approach to Disease
Cataract as a Protein-Aggregation Disease
MEDICAL ASPECTS OF DISEASE: DIAGNOSIS AND CURRENT THERAPIES
Imaging of Misfolded Proteins
Diagnosis of Systemic Amyloid Diseases
Identification of Biomarkers for Diagnosis of Amyloid Diseases: Quantitative Free Light-Chain Assays
Current and Future Therapies for Alzheimer Disease
Current Therapies for Light-Chain Amyloidosis
Identifying Targets in a-Synuclein Metabolism to Treat
Parkinson Disease and Related Disorders
Examination Methods
Scritto. Domande aperte su argomenti del programma.
